The myotubularin family of lipid phosphatases in disease and in spermatogenesis

Biochemical Journal

Volumn 433, Issue 2, 2011, Pages 253-262

  Mruk, Dolores D ^a   Cheng, C Yan ^a  

^a POPULATION COUNCIL   (United States)

Author keywords

Endocytosis; Lipid second messenger; Myotubularin (MTM); Phosphatidylinositol 3 phosphatase; Spermatogenesis; Testis

Indexed keywords

ACTIN RELATED PROTEIN 2; ACTIN RELATED PROTEIN 3; ATALUREN; DYNAMIN II; MYOTUBULARIN; PROTEIN; UNCLASSIFIED DRUG;

CELL FUNCTION; CELL JUNCTION; CENTRONUCLEAR MYOPATHY; CYSTIC FIBROSIS; CYTOSKELETON; DUCHENNE MUSCULAR DYSTROPHY; ENDOCYTOSIS; GENE THERAPY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MUSCLE WEAKNESS; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE SRC; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SEMINIFEROUS TUBULE EPITHELIUM; SPERMATOGENESIS; STEM CELL TRANSPLANTATION; TESTIS;

ANIMALS; HUMANS; MALE; MODELS, BIOLOGICAL; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; SPERMATOGENESIS; TESTIS;

EID: 78651317521     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20101267     Document Type: Review

References (152)

1. Amann, R. P. (2008) The cycle of the seminiferous epithelium in human: a need to revisit? J. Androl. 29, 469-487
2. Ehmcke, J. and Schlatt, S. (2006) A revised model for spermatogonial expansion in man: lessons from non-human primates. Reproduction 132, 673-680
3. Clermont, Y. (1972) Kinetics of spermatogenesis in mammals: seminiferous epithelium cycle and spermatogonial renewal. Physiol. Rev. 52, 198-235
4. Clermont, Y. and Perey, B. (1957) Quantitative study of the cell population of the seminiferous tubules in immature rats. J. Anat. 100, 241-267
5. de Kretser, D. M. and Kerr, J. B. (1988) The cytology of the testis. In The Physiology of Reproduction. (Knobil, E., Neill, J. B., Ewing, L. L., Greenwald, G. S., Markert, C. L. and Pfaff, D. W., eds), pp. 837-932, Raven Press, New York
6. Kerr, J. B., Loveland, K. L., O'Bryan, M. K. and de Kretser, D. M. (2006) Cytology of the testis and intrinsic control mechanisms. In Knobil and Neill's Physiology of Reproduction (Neill, J. D., ed.), pp. 827-947, Elsevier, New York
7. Yan, H. H. N., Mruk, D. D., Lee, W. M. and Cheng, C. Y. (2008) Blood-testis barrier dynamics are regulated by testosterone and cytokines via their differential effects on the kinetics of protein endocytosis and recycling in Sertoli cells. FASEB J. 22, 1945-1959
8. Xia, W., Wong, E. W. P., Mruk, D. D. and Cheng, C. Y. (2009) TGF-β3 and TNFα perturb blood - testis barrier (BTB) dynamics by accelerating the clathrin-mediated endocytosis of integral membrane proteins: a new concept of BTB regulation during spermatogenesis. Dev. Biol. 327, 48-61
9. Guttman, J. A., Takai, Y. and Vogl, A. W. (2004) Evidence that tubulobulbar complexes in the seminiferous epithelium are involved in the internalization of adhesion junctions. Biol. Reprod. 71, 548-559
10. Kusumi, N., Watanabe, M., Yamada, H., Li, S. A., Kashiwakura, Y., Matsukawa, T., Nagai, A., Nasu, Y., Kumon, H. and Takei, K. (2007) Implication of amphiphysin 1 and dynamin 2 in tubulobulbar complex formation and spermatid release. Cell Struct. Funct. 32, 101-113
11. Young, J. S., Guttman, J. A., Vaid, K. S., Shahinian, H. and Vogl, A. W. (2009) Cortactin (CTTN), N-WASP (WASL) and clathrin (CLTC) are present at podosome-like tubulobulbar complexes in the rat testis. Biol. Reprod. 80, 153-161
12. Blondeau, F., Laporte, J., Bodin, S., Superti-Furga, G., Payrastre, B. and Mandel, J. L. (2000) Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum. Mol. Genet. 9, 2223-2229
13. Taylor, G. S., Maehama, T. and Dixon, J. E. (2000) Inaugural article: myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc. Natl. Acad. Sci. U.S.A. 97, 8910-8915
14. Schaletzky, J., Dove, S. K., Short, B., Lorenzo, O., Clague, M. J. and Barr, F. A. (2003) Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol-3-phosphatases. Curr. Biol. 13, 504-509
15. Taylor, G. S., Maehama, T. and Dixon, J. E. (2000) Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc. Natl. Acad. Sci. U.S.A. 97, 8910-8915
16. Di Paolo, G. and De Camilli, P. (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443, 651-657
17. Mochizuki, Y. and Majerus, P. W. (2003) Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9. Proc. Natl. Acad. Sci. U.S.A. 100, 9768-9773
18. Laporte, J., Bedez, F., Bolino, A. and Mandel, J. L. (2003) Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases. Hum. Mol. Genet. 12, R285-R292
19. Begley, M. J. and Dixon, J. E. (2005) The structure and regulation of myotubularin phosphatases. Curr. Opin. Struct. Biol. 15, 614-620
20. Claugue, M. J. and Lorenzo, O. (2005) The myotubularin family of lipid phosphatases. Traffic 6, 1063-1069
21. Doerks, T., Strauss, M., Brendel, M. and Bork, P. (2000) GRAM, a novel domain in glucosyltransferases, myotubularins and other putative membrane-associated proteins. Trends Biochem. Sci. 25, 483-485
22. Tsujita, K., Itoh, T., Ijuin, T., Yamamoto, A., Shisheva, A., Laporte, J. and Takenawa, T. (2004) Myotubularin regulates the function of the late endosome through the GRAM domain - phosphatidylinositol 3,5-biphosphate interaction. J. Biol. Chem. 279, 13817-13824
23. Lorenzo, O., Urbe, S. and Clague, M. J. (2005) Analysis of phosphoinositide binding domain properties within the myotubularin-related protein MTMR3. J. Cell Sci. 118, 2005-2012
24. Laporte, J., Blondeau, F., Gansmuller, A., Lutz, Y., Vonesch, J. L. and Mandel, J. L. (2002) The PtdIns3 P phosphatase myotubularin is a cytoplasmic protein that also localizes to Rac1-inducible plasma membrane ruffles. J. Cell Sci. 115, 3105-3117
25. Cui, X., De Vivo, I., Slany, R., Miyamoto, A., Firestein, R. and Cleary, M. L. (1998) Association of SET domain and myotubularin-related proteins modulates growth control. Nat. Genet. 18, 331-337
26. Nandurkar, H. N., Layton, M., Laporte, J., Selan, C., Corcoran, L., Caldwell, K. K., Mochizuki, Y., Majerus, P. W. and Mitchell, C. A. (2003) Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP. Proc. Natl. Acad. Sci. U.S.A. 100, 8660-8665
27. Wishart, M. J. and Dixon, J. E. (1998) Gathering STYX: phosphatase-like form predicts functions for unique protein-interaction domains. Trends Biochem. Sci. 23, 301-306
28. Berger, P., Schaffitzel, C., Berger, I., Ban, N. and Suter, U. (2003) Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module. Proc. Natl. Acad. Sci. U.S.A. 100, 12177-12182
29. Robinson, F. L. and Dixon, J. E. (2005) The phosphoinositide-3- phosphatase MTMR2 associates with MTMR13, a membrane-associated pseudophosphatase also mutated in type 4B Charcot - Marie - Tooth disease. J. Biol. Chem. 280, 31699-31707
30. Kim, S. A., Vacratsis, P. O., Firestein, R., Cleary, M. L. and Dixon, J. E. (2003) Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase. Proc. Natl. Acad. Sci. U.S.A. 100, 4492-4497
31. Lorenzo, O., Urbe, S. and Clague, M. J. (2006) Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosome-related functions. J. Cell Sci. 119, 2953-2959
32. Berger, P., Berger, I., Schaffitzel, C., Tersar, K., Volkmer, B. and Suter, U. (2006) Multi-level regulation of myotubularin-related protein-2 phosphatase activity by myotubularin-related protein-13/set-binding factor-2. Hum. Mol. Genet. 15, 569-579
33. Berger, P., Schaffitzel, C., Berger, I., Ban, N. and Suter, U. (2003) Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module. Proc. Natl. Acad. Sci. U.S.A. 100, 12177-12182
34. Dang, H., Li, Z., Skolnik, E. Y. and Fares, H. (2004) Disease-related myotubularins function in endocytic traffic in Caenorhabditis elegans. Mol. Biol. Cell 15, 189-196
35. Zou, J., Chang, S. C., Marjanovic, J. and Majerus, P. W. (2009) MTMR9 increases enzyme activity, stability, and role in apoptosis. J. Biol. Chem. 284, 2064-2071
36. Michell, R. H., Heath, V. L., Lemmon, M. A. and Dove, S. K. (2006) Phosphatidylinositol 3,5-biphosphate: metabolism and cellular functions. Trends Biochem. Sci. 31, 52-63
37. Haucke, V. and Di Paolo, G. (2007) Lipids and lipid modifications in the regulation of membrane traffic. Curr. Opin. Cell Biol. 19, 426-435
38. Montagnac, G. and Chavrier, P. (2010) Abscission accomplished by PtdIns(3) P. Nat. Cell Biol. 12, 308-310
39. Burman, C. and Ktistakis, N. T. (2010) Regulation of autophagy by phosphatidylinositol 3-phosphate. FEBS Lett. 584, 1302-1312
40. Backer, J. M. (2000) Phosphoinositide 3-kinases and the regulation of vesicular trafficking. Mol. Cell Biol. Res. Commun. 3, 193-204
41. Gillooly, D. J., Morrow, I. C., Lindsay, M., Gould, R., Bryant, N. J., Gaullier, J. M., Parton, R. G. and Stenmark, H. (2000) Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J. 19, 4577-4588
42. Roth, M. G. (2004) Phosphoinositides in constitutive membrane traffic. Physiol. Rev. 84, 699-730
43. Laporte, J., Liaubet, L., Blondeau, F., Tronchere, H., Mandel, J. L. and Payrastre, B. (2002) Functional redundancy in the myotubularin family. Biochem. Biophys. Res. Commun. 291, 305-312
44. Kim, S. A., Taylor, G. S., Torgersen, K. M. and Dixon, J. E. (2002) Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease. J. Biol. Chem. 277, 4526-4531
45. Chaussade, C., Pirola, L., Bonnafous, S., Blondeau, F., Brenz-Verca, S., Tronchere, H., Portis, F., Rusconi, S., Payrastre, B., Laporte, J. and Van Obberghen, E. (2003) Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3) P] phosphatase in muscle cells: involvement of PtdIns(3) P in insulin-stimulated glucose transport. Mol. Endocrinol. 17, 2448-2460
46. Lemmon, M. A. (2003) Phosphoinositide recognition domains. Traffic 4, 201-213
47. Gaullier, J. M., Ronning, E., Gillooly, D. J. and Stenmark, H. (2000) Interaction of the EEA1 FYVE finger with phosphatidylinositol 3-phosphate and early endosomes. Role of conserved residues. J. Biol. Chem. 275, 24595-24600
48. Cao, C., Laporte, J., Backer, J. M., Wandinger-Ness, A. and Stein, M. P. (2007) Myotubularin lipid phosphatase binds the hVPS15/hVPS34 lipid kinase complex on endosomes. Traffic 8, 1052-1067
49. Backer, J. M. (2008) The regulation and function of Class III PI3Ks: novel roles for Vps34. Biochem. J. 410, 1-17
50. Cao, C., Backer, J. M., Laporte, J., Bedrick, E. J. and Wandinger-Ness, A. (2008) Sequential actions of myotubularin lipid phosphatases regulate endosomal PI(3)P and growth factor receptor trafficking. Mol. Biol. Cell 19, 3334-3346
51. Pendaries, C., Tronchere, H., Plantavid, M. and Payrastre, B. (2003) Phosphoinositide signaling disorders in human disease. FEBS Lett. 546, 25-31
52. Beckers, C. M. L., van Hinsbergh, V. W. M. and van Nieuw Amerongen, G. P. (2010) Driving Rho GTPase activity in endothelial cells regulates barrier integrity. Thromb. Haemost. 103, 40-55
53. Nelson, W. J. (2008) Regulation of cell-cell adhesion by the cadherin-catenin complex. Biochem. Soc. Trans. 36, 149-155
54. Vandenbroucke, E., Mehta, D., Minshall, R. and Malik, A. B. (2008) Regulation of endothelial junctional permeability. Ann. N. Y. Acad. Sci. 1123, 134-145
55. Griffiths, G. M., Tsun, A. and Stinchcombe, J. C. (2010) The immunological synapse: a focal point for endocytosis and exocytosis. J. Cell Biol. 189, 399-406
56. Troyanovsky, S. M. (2009) Regulation of cadherin-based epithelial cell adhesion by endocytosis. Front. Biosci. 1, 61-67
57. Komarova, Y. and Malik, A. B. (2010) Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu. Rev. Physiol. 72, 463-493
58. Mei, J., Li, Z. and Gui, J. F. (2009) Cooperation of Mtmr8 with PI3K regulates actin filament modeling and muscle development in zebrafish. PLoS One 4, e4979
59. Bolis, A., Coviello, S., Visigalli, I., Taveggia, C., Bachi, A., Chishti, A. H., Hanada, T., Quattrini, A., Previtali, S. C., Biffi, A. and Bolino, A. (2009) Dlg1, Sec8, and Mtmr2 regulate membrane homeostasis in Schwann cell myelination. J. Neurosci. 29, 8858-8870
60. Bolino, A., Bolis, A., Previtali, S. C., Dina, G., Bussini, S., Dati, G., Amadio, S., Del Carro, U., Mruk, D. D., Feltri, M. L. et al. (2004) Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis. J. Cell Biol. 167, 711-721
61. Humbert, P., Russell, S. and Richardson, H. (2003) Dlg, Scribble and Lgl in cell polarity, cell proliferation and cancer. BioEssays 25, 542-553
62. Humbert, P. O., Grzeschik, N. A., Brumby, A. M., Galea, R., Elsum, I. A. and Richardson, H. E. (2008) Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module. Oncogene 27, 6888-6907
63. Robinson, F. L. and Dixon, J. E. (2006) Myotubularin phosphatases: policing 3-phosphoinositides. Trends Cell Biol. 16, 403-412
64. Nicot, A. S. and Laporte, J. (2008) Endosomal phosphoinositides and human disease. Traffic 9, 1240-1249
65. Thomas, N. S., Williams, H., Cole, G., Roberts, K., Clarke, A., Liechti-Gallati, S., Braga, S., Gerber, A., Meier, C., Moser, H. and Harper, P. S. (1990) X-linked centronuclear/myotubular myopathy: evidence for linkage to Xq28 marker loci. J. Med. Genet. 27, 284-287
66. Liechti-Gallati, S., Mueller, B., Grimm, T., Kress, W., Mueller, C., Boltshauser, E., Moser, H. and Braga, S. (1991) X-linked centronuclear myopathy: mapping the gene to Xq28. Neuromuscul. Disord. 1, 239-245
67. 65a van Wijngaarden, G. K., Fleury, P., Bethlem, J. and Meijer, A. E. (1969) Familial 'myotubular' myopathy. Neurology 19, 901-908
68. Buj-Bello, A., Laugel, V., Messaddeq, N., Zahreddine, H., Laporte, J., Pellissier, J. F. and Mandel, J. L. (2002) The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc. Natl. Acad. Sci. U.S.A. 99, 15060-15065
69. Prendergast, G. C., Muller, A. J., Ramalingam, A. and Chang, M. Y. (2009) BAR the door: cancer suppression by amphiphysin-like genes. Biochim. Biophys. Acta 1795, 25-36
70. Kasai, K., Shin, H. W., Shinotsuka, C., Murakami, K. and Nakayama, K. (1999) Dynamin II is involved in endocytosis but not in the formation of transport vesicles from the trans-Golgi network. J. Biochem. 125, 780-789
71. McClure, S. J. and Robinson, P. J. (1996) Dynamin, endocytosis and intracellular signalling. Mol. Membr. Biol. 13, 189-215
72. Nicot, S. A., Toussaint, A., Tosch, V., Kretz, C., Wallgren-Pettersson, C., Iwarsson, E., Kingston, H., Garnier, J. M., Biancalana, V., Oldfors, A. et al. (2007) Mutations in amphiphysin 2 ( BIN1) disrupt interactions with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat. Genet. 39, 1134-1139
73. Bitoun, M., Maugenre, S., Jeannet, P. Y., Lacene, E., Ferrer, X., Laforet, P., Martin, J. J., Laporte, J., Lochmuller, H., Beggs, A. H. et al. (2005) Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat. Genet. 37, 1207-1209
74. Jaradeh, S. S. (2003) Hereditary neuropathies. J. Clin. Neuromuscul. Dis. 5, 72-80
75. Banchs, I., Casasnovas, C., Alberti, A., De Jorge, L., Povedano, M., Montero, J., Martinez-Matos, J. A. and Volpini, V. (2009) Diagnosis of Charcot-Marie-Tooth disease. J. Biomed. Biotechnol. 2009, 985415
76. Azzedine, H., Bolino, A., Taieb, T., Birouk, N., Di Duca, M., Bouhouche, A., Benamou, S., Mrabet, A., Hammadouche, T., Chkili, T. et al. (2003) Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am. J. Hum. Genet. 72, 1141-1153
77. Senderek, J., Bergmann, C., Weber, S., Ketelsen, U. P., Schorle, H., Rudnik-Schoneborn, S., Buttner, R., Buchheim, E. and Zerres, K. (2003) Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum. Mol. Genet. 12, 349-356
78. Stenmark, H. (2009) Rab GTPases as coordinators of membrane traffic. Nat. Rev. Mol. Cell Biol. 10, 513-525
79. Somsel Rodman, J. and Wandinger-Ness, A. (2000) Rab GTPases coordinate endocytosis. J. Cell Sci. 113, 183-192
80. Verhoeven, K., De Jonghe, P., Coen, K., Verpoorten, N., Auer-Grumbach, M., Kwon, J. M., FitzPatrick, D., Schmedding, E., De Vriendt, E., Jacobs, A. et al. (2003) Mutations in the small GTPase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am. J. Hum. Genet. 72, 722-727
81. Meggouh, F., Bienfait, H. M., Weterman, M. A., de Visser, M. and Baas, F. (2006) Charcot-Marie-Tooth disease due to a de novomutation of the RAB7 gene. Neurology 67, 1476-1478
82. Fabrizi, G. M., Ferrarini, M., Cavallaro, T., Cabrini, I., Cerini, R., Bertolasi, L. and Rizzuto, N. (2007) Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease. Neurology 69, 291-295
83. Zuchner, S., Noureddine, M., Kennerson, M., Verhoeven, K., Claeys, K., De Jonghe, P., Merory, J., Oliveira, S. A., Speer, M. C., Stenger, J. E. et al. (2005) Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat. Genet. 37, 289-294
84. Roberts, R. C., Peden, A. A., Buss, F., Bright, N. A., Latouche, M., Reilly, M. M., Kendrick-Jones, J. and Luzio, J. P. (2010) Mistargeting of SH3TC2 away from the recycling endosome causes Charcot-Marie-Tooth disease type 4C. Hum. Mol. Genet. 19, 1009-1018
85. Lupo, V., Galindo, M. I., Martinez-Rubio, D., Sevilla, T., Vilchez, J. J., Palau, F. and Espinos, C. (2009) Missense mutations in the SH3TC2 protein causing Charcot-Marie-Tooth disease type 4C affect its localization in the plasma membrane and endocytic pathway. Hum. Mol. Genet. 18, 4603-4614
86. Laird, D. W. (2010) The gap junction proteome and its relationship to disease. Trends Cell Biol. 20, 92-101
87. Herve, J. C., Bourmeyster, N. and Sarrouilhe, D. (2004) Diversity in protein-protein interactions of connexins: emerging roles. Biochim. Biophys. Acta 1662, 22-41
88. Bergoffen, J., Scherer, S. S., Wang, S., Scott, M. O., Bone, L. J., Paul, D. L., Chen, K., Lensch, M. W., Chance, P. F. and Fischbeck, K. H. (1993) Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262, 2039-2042
89. Braathen, G. J., Sand, J. C., Bukholm, G. and Russell, M. B. (2007) Two novel connexin32 mutations cause early onset X-linked Charcot-Marie-Tooth disease. BMC Neurol. 7, 19
90. Firestein, R., Nagy, P. L., Daly, M., Huie, P., Conti, M. and Cleary, M. L. (2002) Male infertility, impaired spermatogenesis, and azoospermia in mice deficient for pseudophosphatase Sbfl. J. Clin. Invest. 109, 1165-1172
91. 87a Bolino, A., Bolis, A, Previtali, S. C., Dina, G., Bussini, S., Dati, G., Amadio, S., Del Carro, U., Mruk, D. D., Feltri, M. L. et al. (2004) Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis. J. Cell. Biol. 167, 711-721
92. Li, J. C., Samy, E. T., Grima, J., Chung, S. S. W., Mruk, D., Lee, W. M., Silvestrini, B. and Cheng, C. Y. (2000) Rat testicular myotubularin, a protein tyrosine phosphatase expressed by Sertoli and germ cells, is a potential marker for studying cell-cell interactions in the rat testis. J. Cell. Physiol. 185, 366-385
93. Li, J. C. H., Lee, W. M., Mruk, D. D. and Cheng, C. Y. (2001) Regulation of Sertoli cell myotubularin (rMTM) expression by germ cells in vitro. J. Androl. 22, 266-277
94. Zhang, J., Wong, C. H., Xia, W., Mruk, D. D., Lee, N. P., Lee, W. M. and Cheng, C. Y. (2005) Regulation of Sertoli-germ cell adherens junction dynamics via changes in protein-protein interactions of the N-cadherin-β-catenin protein complex which are possibly mediated by c-Src and myotubularin-related protein 2: an in vivo study using an androgen suppression model. Endocrinology 146, 1268-1284
95. Cheng, C. Y., Silvestrini, B., Grima, J., Mo, M. Y., Zhu, L. J., Johansson, E., Saso, L., Leone, M. G., Palmery, M. and Mruk, D. D. (2001) Two new male contraceptives exert their effects by depleting germ cells prematurely from the testis. Biol. Reprod. 65, 449-461
96. Grima, J., Silvestrini, B. and Cheng, C. Y. (2001) Reversible inhibition of spermatogenesis in rats using a new male contraceptive, 1-(2,4- dichlorobenzyl)- indazole-3-carbohydrazide. Biol. Reprod. 64, 1500-1508
97. Mruk, D. D., Wong, C. H., Silvestrini, B. and Cheng, C. Y. (2006) A male contraceptive targeting germ cell adhesion. Nat. Med. 12, 1323-1328
98. Russell, L. D. (1993) Morphological and functional evidence for Sertoli-germ cell relationships. In The Sertoli Cell (Russell, L. D. and Griswold, M. D., eds), pp. 365-390, Cache River Press, Clearwater
99. Mruk, D. D. and Cheng, C. Y. (2004) Cell-cell interactions at the ectoplasmic specialization in the testis. Trends Endocrinol. Metab. 15, 439-447
100. Cheng, C. Y. and Mruk, D. D. (2002) Cell junction dynamics in the testis: Sertoli-germ cell interactions and male contraceptive development. Physiol. Rev. 82, 825-874
101. Russell, L. D. (1979) Observations on the inter-relationships of Sertoli cells at the level of the blood-testis barrier: evidence for formation and resorption of Sertoli-Sertoli tubulobulbar complexes during the spermatogenic cycle of the rat. Am. J. Anat. 155, 259-279
102. Russell, L. D. (1979) Further observations on tubulobulbar complexes formed by late spermatids and Sertoli cells in the rat testis. Anat. Rec. 194, 213-232
103. Lee, N. P. and Cheng, C. Y. (2005) Protein kinases and adherens junction dynamics in the seminiferous epithelium of the rat testis. J. Cell. Physiol. 202, 344-360
104. Guarino, M. (2010) Src signaling in cancer invasion. J. Cell. Physiol. 223, 14-26
105. Huveneers, S. and Danen, E. H. J. (2009) Adhesion signaling: crosstalk between integrins, Src and Rho. J. Cell Sci. 122, 1059-1069
106. Kim, L. C., Song, L. and Haura, E. B. (2009) Src kinases as therapeutic targets for cancer. Nat. Rev. Clin. Oncol. 6, 587-595
107. Benati, D. and Baldari, C. T. (2008) SRC family kinases as potential therapeutic targets for malignancies and immunological disorders. Curr. Med. Chem. 15, 1154-1165
108. Wang, W., Wine, R. N. and Chapin, R. E. (2000) Rat testicular Src: normal distribution and involvement in ethylene glycol monomethyl ether-induced apoptosis. Toxicol. Appl. Pharmacol. 163, 125-134
109. Wong, C. H., Xia, W., Lee, N. P. Y., Mruk, D. D., Lee, W. M. and Cheng, C. Y. (2005) Regulation of ectoplasmic specialization dynamics in the seminiferous epithelium by focal adhesion-associated proteins in testosterone-suppressed rat testes. Endocrinology 146, 1192-1204
110. Piedra, J., Martinez, D., Castano, J., Miravete, S., Dunach, M. and Herreros, A. G. (2001) Regulation of β-catenin structure and activity by tyrosine phosphorylation. J. Biol. Chem. 276, 20436-20443
111. Lilien, J. and Balsamo, J. (2005) The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of β-catenin. Curr. Opin. Cell Biol. 17, 459-465
112. Matsuyoshi, N., Hamaguchi, M., Taniguchi, S., Nagafuchi, A., Tsukita, S. and Takeichi, M. (1992) Cadherin-mediated cell-cell adhesion is perturbed by v-Src tyrosine phosphorylation in metastatic fibroblasts. J. Cell Biol. 118, 703-714
113. Li, J. C. H., Mruk, D. D. and Cheng, C. Y. (2001) The inter-Sertoli tight junction permeability barrier is regulated by the inter-play of protein phosphatases and kinases: an in vitro study. J. Androl. 22, 847-856
114. Sandilands, E., Cans, C., Fincham, V. J., Brunton, V. G., Mellor, H., Prendergast, G. C., Norman, J. C., Superti-Furga, G. and Frame, M. C. (2004) RhoB and actin polymerization coordinate Src activation with endosome-mediated delivery to the membrane. Dev. Cell 7, 855-869
115. Gasman, S., Kalaidzidis, Y. and Zerial, M. (2003) RhoD regulates endosome dynamics through Diaphanous-related formin and Src tyrosine kinase. Nat. Cell Biol. 5, 195-204
116. Ellis, S. and Mellor, H. (2000) Regulation of endocytic traffic by Rho family GTPases. Trends Cell Biol. 10, 85-88
117. Sverdlov, M., Shajahan, A. N. and Minshall, R. D. (2007) Tyrosine phosphorylationdependence of caveolae-mediated endocytosis. J. Cell. Mol. Med. 11, 1239-1250
118. Lajoie, P. and Nabi, I. R. (2010) Lipid rafts, caveolae and their endocytosis. Int. Rev. Cell Mol. Biol. 282, 135-163
119. Stephan, J. P., Syed, V. and Jegou, B. (1997) Regulation of Sertoli cell IL-1 and IL-6 production in vitro. Mol. Cell. Endocrinol. 134, 109-118
120. Syed, V., Stephan, J. P., Gerard, N., Legrand, A., Parvinen, M., Bardin, C. W. and Jegou, B. (1995) Residual bodies activate Sertoli cell interleukin-1α (IL-1α) release, which triggers IL-6 production by an autocrine mechanism, through the lipoxygenase pathway. Endocrinology 136, 3070-3078
121. Korolchuk, V. and Banting, G. (2003) Kinases in clathrin-mediated endocytosis. Biochem. Soc. Trans. 31, 857-860
122. Shajahan, A. N., Timblin, B. K., Sandoval, R. M., Tiruppathi, C., Malik, A. B. and Minshall, R. D. (2004) Role of Src-induced dynamin-2 phosphorylation in caveolae-mediated endocytosis in endothelial cells. J. Biol. Chem. 279, 20392-20400
123. Hirsch, D. S., Shen, Y., Dokmanovic, M. and Wu, W. J. (2010) pp60s-Src phosphorylates and activates vacuolar protein sorting 34 to mediate cellular transformation. Cancer Res. 70, 5974-5983
124. Vaid, K. S., Guttman, J. A., Babyak, N., Deng, W., McNiven, M. A., Mochizuki, N., Finlay, B. B. and Vogl, A. W. (2007) The role of dynamin 3 in the testis. J. Cell. Physiol. 210, 644-654
125. Lie, P. P. Y., Xia, W., Wang, C. Q., Mruk, D. D., Yan, H. H., Wong, C. H., Lee, W. M. and Cheng, C. Y. (2006) Dynamin II interacts with the cadherin- and occludin-based protein complexes at the blood-testis barrier in adult rat testes. J. Endocrinol. 191, 571-586
126. Lie, P. P. Y., Chan, A. Y. N., Mruk, D. D., Lee, W. M. and Cheng, C. Y. (2010) Restricted Arp3 expression in the testis prevents blood-testis barrier disruption during junction restructuring at spermatogenesis. Proc. Natl. Acad. Sci. U.S.A. 107, 11411-11416
127. Gumbiner, B. M. (2000) Regulation of cadherin adhesive activity. J. Cell Biol. 148, 399-403
128. Kikyo, M., Matozaki, T., Kodama, A., Kawabe, H., Nakanishi, H. and Takai, Y. (2000) Cell-cell adhesion-mediated tyrosine phosphorylation of nectin-2δ, an immunoglobulin-like cell adhesion molecule at adherens junctions. Oncogene 19, 4022-4028
129. Mruk, D. D. and Cheng, C. Y. (2004) Sertoli-Sertoli and Sertoli-germ cell interactions and their significance in germ cell movement in the seminiferous epithelium during spermatogenesis. Endocr. Rev. 25, 747-806
130. Morrison, D. K. (2008) The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol. 19, 16-23
131. Nandurkar, H. H., Caldwell, K. K., Whisstock, J. C., Layton, M. J., Gaudet, E. A., Norris, F. A., Majerus, P. W. and Mitchell, C. A. (2001) Characterization of an adapter subunit to a phosphatidylinositol(3)P 3-phosphatase: identification of a myotubularin-related protein lacking catalytic activity. Proc. Natl. Acad. Sci. U.S.A. 98, 9499-9504
132. Wong, E. W. P., Sun, S. C., Li, M. W. M., Lee, W. M. and Cheng, C. Y. (2009) 14-3-3 protein regulates cell adhesion in the seminiferous epithelium of rat testes. Endocrinology 150, 4713-4723
133. Di Fiore, P. P. and Scita, G. (2002) Eps8 in the midst of GTPases. Int. J. Biochem. Cell Biol. 34, 1178-1183
134. Scita, G., Nordstrom, J., Carbone, R., Tenca, P., Giardina, G., Gutkind, S., Bjarnegard, M., Betsholtz, C. and Di Fiore, P. P. (1999) EPS8 and E3B1 transduce signals from Ras to Rac. Nature 401, 290-293
135. Lie, P. P. Y., Mruk, D. D., Lee, W. M. and Cheng, C. Y. (2009) Epidermal growth factor receptor pathway substrate 8 (Eps8) is a novel regulator of cell adhesion and the blood-testis barrier integrity in the seminiferous epithelium. FASEB J. 23, 2555-2567
136. Cheng, C. Y. and Mruk, D. D. (2010) A local autocrine axis in the testes that regulates spermatogenesis. Nat. Rev. Endocrinol. 6, 380-395
137. Welsch, T., Younsi, A., Disanza, A., Rodriguez, J. A., Cuervo, A. M., Scita, G. and Schmidt, J. (2010) Eps8 is recruited to lysosomes and subjected to chaperone-mediated autophagy in cancer cells. Exp. Cell Res. 316, 1914-1924
138. Lanzetti, L., Rybin, V., Malabarba, M. G., Christoforidis, S., Scita, G., Zerial, M. and Di Fiore, P. P. (2000) The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5. Nature 408, 374-377
139. Hertzog, M., Milanesi, F., Hazelwood, L., Disanza, A., Liu, H. J., Perlade, E., Malabarba, M. G., Pasqualato, S., Maiolica, A., Confalonieri, S. et al. (2010) Molecular basis for the dual function of Eps8 on actin dynamics: bundling and capping. PLoS Biol. 8, e1000387
140. Kuehn, B. M. (2007) Studies point way to new therapeutic prospects for muscular dystrophy. JAMA, J. Am. Med. Assoc. 298, 1385-1386
141. Hirawat, S., Welch, E. M., Elfring, G. L., Northcutt, V. J., Paushkin, S., Hwang, S., Leonard, E. M., Almstead, N. G., Ju, W., Peltz, S. W. and Miller, L. L. (2007) Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers. J. Clin. Pharmacol. 47, 430-444
142. Du, M., Liu, X., Welch, E. M., Hirawat, S., Peltz, S. W. and Bedwell, D. M. (2008) PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model. Proc. Natl. Acad. Sci. U.S.A. 105, 2064-2069
143. Welch, E. M., Barton, E. R., Zhuo, J., Tomizawa, Y., Friesen, W. J., Trifillis, P., Paushkin, S., Patel, M., Trotta, C. R., Hwang, S. et al. (2007) PTC124 targets genetic disorders caused by nonsense mutations. Nature 447, 87-91
144. Kerem, E., Hirawat, S., Armoni, S., Yaakov, Y., Shoseyov, D., Cohen, M., Nissim-Rafinia, M., Blau, H., Rivlin, J., Aviram, M. et al. (2008) Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet 372, 719-727
145. Henderson, M. (2007) Daily pill to beat genetic diseases. The Times (http://www. timesonline.co.uk/tol/news/science/article1690544. ece)
146. Chan, H. C., Ruan, Y. C., He, Q., Chen, M. H., Chen, H., Xu, W. M., Chen, W. Y., Xie, C., Zhang, X. H. and Zhou, Z. (2009) The cystic fibrosis transmembrane conductance regulator in reproductive health and disease. J. Physiol. 587, 2187-2195
147. Parekh-Olmedo, H. and Kmiec, E. B. (2007) Progress and prospects: targeted gene alteration (TGA). Gene Ther. 14, 1675-1680
148. Rando, T. A., Disatnik, M. H. and Zhou, L. Z. (2000) Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides. Proc. Natl. Acad. Sci. U.S.A. 97, 5363-5368
149. Bertoni, C. and Rando, T. A. (2002) Dystrophin gene repair in mdx muscle precursor cells in vitroand in vivo mediated by RNA-DNA chimeric oligonucleotides. Hum. Gene Ther. 13, 707-718
150. LaBarge, M. A. and Blau, H. M. (2002) Biological progression from bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111, 589-601
151. Ferrari, G., Cusella-De Angelis, G., Coletta, M., Paolucci, E., Stornaiuolo, A., Cossu, G. and Mavilio, F. (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279, 1528-1530
152. Camargo, F. D., Green, R., Capetenaki, Y., Jackson, K. A. and Goodell, M. A. (2003) Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat. Med. 12, 1520-1527